-
US FDA issues 'Official Action Indicated' status to Sun Pharma’s Baska facility after inspection
18 Dec 2025 03:42 GMT
… investor focus on Sun Pharma’s overseas manufacturing footprint, … restraining domestic sales until March 2026, when Danish drugmaker Novo … barred sales in the Indian market, directing Sun Pharma to … seeking to restrain Sun Pharma from manufacturing and selling …
-
AbbVie, several other pharma companies near MFN deal with Trump, sources say
17 Dec 2025 21:53 GMT
… ) – AbbVie and several other drugmakers are expected to announce on … leaders of 17 major pharmaceutical companies outlining how they … He also called on the drugmakers to reinvest their earnings … to implement direct-to-consumer sales models.
FIVE RESPONSES SO …
-
Pfizer faces challenging years on fading COVID sales, margin pressure
16 Dec 2025 19:52 GMT
… with 2026, due to lower sales of its COVID vaccine and … peers in performance.
The drugmaker does not expect to return … MISS WALL STREET TARGETS
The drugmaker expects 2026 adjusted profit per … Pfizer was the first major pharmaceutical company to sign a deal …
-
Pfizer sees flat 2026 sales as it rebuilds drug pipeline
16 Dec 2025 18:31 GMT
… to no sales growth next year as the drugmaker undertakes an … The circumstances have forced the drugmaker to undertake a major cost … just two pharmaceutical companies that’s expected to see sales contract … A/S for obesity drugmaker Metsera Inc.
The $10 …
-
Pfizer Signs Around $2.1bn Licensing Deal with YaoPharma
18 Dec 2025 16:47 GMT
… weight loss space of the pharmaceutical giant.
Pfizer, as per … subsidiary of Shanghai Fosun Pharmaceutical, the Chinese drugmaker, an up-front … addition to tiered royalties on sales if this drug gets … past two years. The drugmaker has boosted its prospects in …
-
UK, US approve GSK's twice-yearly asthma drug
17 Dec 2025 13:55 GMT
Regulators in the UK and US are the first to approve GSK's Exdensur, a long-acting, twice-yearly IL-5 inhibitor for severe asthma that has been billed as a major new product for the drugmaker.
In the UK – the first market for the drug – the MHRA has …
-
Takeda Rises After AI-Developed Psoriasis Pill Trial Success
19 Dec 2025 01:34 GMT
(Bloomberg) -- Takeda Pharmaceutical Co. rose the most … months on Friday after the drugmaker said its oral psoriasis drug … strategy to cushion an expected sales decline once its blockbuster ulcerative … the drug will generate annual sales of ¥150 billion ($964 …
-
Medicare drug discounts begin in 2026. This is how much…
18 Dec 2025 17:22 GMT
… .
USA TODAY Shopping: Shop sales in tech, home, fashion, … announced deals with several pharmaceutical companies to sell other … the president has pressured drugmakers to lower their prices to … Trump announced deals with drugmakers Eli Lilly and Novo Nordisk …
-
White House Readies Drug Price Deals With AbbVie, Novartis, Roche
18 Dec 2025 15:22 GMT
… ABBV) and several other drugmakers are reportedly expected to … expanded direct-to-consumer sales models.
Five companies—Pfizer … SA (NASDAQ:SNY), Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), … told Bloomberg that additional drugmakers may be included, though …
-
Takeda's AI-crafted psoriasis pill succeeds in late-stage studies
18 Dec 2025 15:18 GMT
… ) - Japan's Takeda Pharmaceutical said on Thursday its experimental … sales in the range of $3 billion to $6 billion. The drugmaker … picking up pace in the pharmaceutical industry as companies seek to …